# DocPlanner

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/docplanner

- Industry: Healthcare IT
- Headquarters: Amsterdam, Netherlands
- Website: www.docplanner.com
- Total disclosed funding: $140M
- Latest round: Series E (May 14, 2019)
- Investors on record: 9

## About

Based in the Netherlands, DocPlanner operates a digital healthcare platform that connects patients with healthcare providers, streamlining appointment bookings and enhancing patient management services across multiple countries.DocPlanner, founded in 2011 in Amsterdam, Netherlands, provides a digital healthcare platform. The company's founders include Grzegorz Krysiak and Lucek Samulowski. In May 2019, DocPlanner raised EUR 80 mn in Series E funding, led by Goldman Sachs Merchant Banking Division, with total funding amounting to EUR 80 mn. The firm has completed 6 deals since inception.DocPlanner Group offers an integrated healthcare ecosystem designed to connect patients with healthcare providers, enhancing the overall patient experience by streamlining appointment booking, improving practice management, and promoting online reputation management for doctors. The primary offerings include a patient-facing platform that allows users to find doctors, book appointments, and address health-related questions, alongside a suite of solutions for healthcare professionals optimizing scheduling, reducing no-shows, and facilitating patient management. Their services reach clients across 13 countries including Poland, Brazil, Mexico, Spain, Italy, Germany, Turkey, Colombia, the Czech Republic, Portugal, Argentina, Peru, and Chile.In 2022, DocPlanner recorded a revenue of EUR 28,202,572 and an EBITDA of EUR 2,512,190. The company generates revenue through subscription models for doctors and clinics utilizing their practice management solutions and through direct partnerships with various healthcare institutions.Following its recent funding round in May 2019, DocPlanner plans to leverage the EUR 80 mn raised to enhance its presence in European and Latin American markets, pursue research and development activities, and expand its team. The company is focused on developing new products aimed at improving patient engagement and operational efficiency for healthcare providers.

## Funding rounds

- Series E, May 14, 2019, $89M — Goldman Sachs Asset Management, Piton Capital, One Peak, KAYA
- Series D, May 24, 2017, $17M — One Peak, Target Global, KAYA
- Series C, Jun 7, 2016, $20M — European Bank for Reconstruction and Development, Target Global, KAYA
- Series B, May 13, 2015, $10M — European Bank for Reconstruction and Development, Port Aventura Entertainment, S.A.U., Piton Capital, Point Nine
- Series A, Sep 12, 2013, $3M — Piton Capital, Point Nine, RTA Ventures
- Series A, Dec 3, 2012, $1M — Piton Capital, Point Nine, RTA Ventures

## Investors

- Piton Capital (https://capitalatlas.ai/funds/piton-capital) — Series A, Series B, Series E
- Point Nine (https://capitalatlas.ai/funds/point-nine) — Series A, Series B
- RTA Ventures (https://capitalatlas.ai/funds/rta-ventures) — Series A
- European Bank for Reconstruction and Development — Series B, Series C
- Port Aventura Entertainment, S.A.U. — Series B
- Target Global (https://capitalatlas.ai/funds/target-global) — Series C, Series D
- KAYA (https://capitalatlas.ai/funds/kaya) — Series C, Series D, Series E
- One Peak (https://capitalatlas.ai/funds/one-peak) — Series D, Series E
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series E